Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis

N. Y. Hsu, K. T. Yeh, I. P. Chiang, L. Y. Pai, C. Y. Chen, Heng Chein Ho

研究成果: 雜誌貢獻文章

16 引文 (Scopus)

摘要

The aim of this study is to examine whether dysregulated expression of cortactin occurs in esophageal squamous cell carcinoma (ESCC) and is involved in the development of ESCCs. An immunohistochemistry study for cortactin expression was performed on 46 pairs of surgically resected non-tumor and ESCC tumor tissues and murine tumors of esophagi induced by a carcinogen. The results show increased cortactin expression in 20 and in 22 to a lesser extent, out of a total 46 ESCC tumor tissues. Increased cortactin was also detected in the premalignant lesions, the early stage dysplasia and carcinoma in situ, of ESCC tumor tissues. Differential polymerase chain reaction results showed slight increases in the EMS1 gene only in two of 10 ESCC tumor tissues, suggesting that EMS1 gene amplification is not the only mechanism for cortactin overexpression. In the mouse model induced by treatment with 4-nitroquinoline 1-oxide and arecoline, increased cortactin was detected in the epithelia with hyperkeratosis, papillomas, and ESCCs with invasion into the submucosa, respectively. Overall, we observed cortactin overexpression in early and late stages of human ESCCs and carcinogen-induced murine ESCCs, suggesting a role for cortactin in esophageal carcinogenesis.
原文英語
頁(從 - 到)402-408
頁數7
期刊Diseases of the Esophagus
21
發行號5
DOIs
出版狀態已發佈 - 八月 2008
對外發佈Yes

指紋

Cortactin
Carcinogenesis
Neoplasms
Carcinogens
Arecoline
4-Nitroquinoline-1-oxide
Esophageal Squamous Cell Carcinoma
Gene Amplification
Carcinoma in Situ
Papilloma
Esophagus
Epithelium
Immunohistochemistry
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Gastroenterology

引用此文

Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis. / Hsu, N. Y.; Yeh, K. T.; Chiang, I. P.; Pai, L. Y.; Chen, C. Y.; Ho, Heng Chein.

於: Diseases of the Esophagus, 卷 21, 編號 5, 08.2008, p. 402-408.

研究成果: 雜誌貢獻文章

Hsu, N. Y. ; Yeh, K. T. ; Chiang, I. P. ; Pai, L. Y. ; Chen, C. Y. ; Ho, Heng Chein. / Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis. 於: Diseases of the Esophagus. 2008 ; 卷 21, 編號 5. 頁 402-408.
@article{5d00300047d847a9a167264bc3317872,
title = "Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis",
abstract = "The aim of this study is to examine whether dysregulated expression of cortactin occurs in esophageal squamous cell carcinoma (ESCC) and is involved in the development of ESCCs. An immunohistochemistry study for cortactin expression was performed on 46 pairs of surgically resected non-tumor and ESCC tumor tissues and murine tumors of esophagi induced by a carcinogen. The results show increased cortactin expression in 20 and in 22 to a lesser extent, out of a total 46 ESCC tumor tissues. Increased cortactin was also detected in the premalignant lesions, the early stage dysplasia and carcinoma in situ, of ESCC tumor tissues. Differential polymerase chain reaction results showed slight increases in the EMS1 gene only in two of 10 ESCC tumor tissues, suggesting that EMS1 gene amplification is not the only mechanism for cortactin overexpression. In the mouse model induced by treatment with 4-nitroquinoline 1-oxide and arecoline, increased cortactin was detected in the epithelia with hyperkeratosis, papillomas, and ESCCs with invasion into the submucosa, respectively. Overall, we observed cortactin overexpression in early and late stages of human ESCCs and carcinogen-induced murine ESCCs, suggesting a role for cortactin in esophageal carcinogenesis.",
keywords = "Arecoline, Cortactin, Esophageal squamous cell carcinoma",
author = "Hsu, {N. Y.} and Yeh, {K. T.} and Chiang, {I. P.} and Pai, {L. Y.} and Chen, {C. Y.} and Ho, {Heng Chein}",
year = "2008",
month = "8",
doi = "10.1111/j.1442-2050.2007.00775.x",
language = "English",
volume = "21",
pages = "402--408",
journal = "Diseases of the Esophagus",
issn = "1120-8694",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis

AU - Hsu, N. Y.

AU - Yeh, K. T.

AU - Chiang, I. P.

AU - Pai, L. Y.

AU - Chen, C. Y.

AU - Ho, Heng Chein

PY - 2008/8

Y1 - 2008/8

N2 - The aim of this study is to examine whether dysregulated expression of cortactin occurs in esophageal squamous cell carcinoma (ESCC) and is involved in the development of ESCCs. An immunohistochemistry study for cortactin expression was performed on 46 pairs of surgically resected non-tumor and ESCC tumor tissues and murine tumors of esophagi induced by a carcinogen. The results show increased cortactin expression in 20 and in 22 to a lesser extent, out of a total 46 ESCC tumor tissues. Increased cortactin was also detected in the premalignant lesions, the early stage dysplasia and carcinoma in situ, of ESCC tumor tissues. Differential polymerase chain reaction results showed slight increases in the EMS1 gene only in two of 10 ESCC tumor tissues, suggesting that EMS1 gene amplification is not the only mechanism for cortactin overexpression. In the mouse model induced by treatment with 4-nitroquinoline 1-oxide and arecoline, increased cortactin was detected in the epithelia with hyperkeratosis, papillomas, and ESCCs with invasion into the submucosa, respectively. Overall, we observed cortactin overexpression in early and late stages of human ESCCs and carcinogen-induced murine ESCCs, suggesting a role for cortactin in esophageal carcinogenesis.

AB - The aim of this study is to examine whether dysregulated expression of cortactin occurs in esophageal squamous cell carcinoma (ESCC) and is involved in the development of ESCCs. An immunohistochemistry study for cortactin expression was performed on 46 pairs of surgically resected non-tumor and ESCC tumor tissues and murine tumors of esophagi induced by a carcinogen. The results show increased cortactin expression in 20 and in 22 to a lesser extent, out of a total 46 ESCC tumor tissues. Increased cortactin was also detected in the premalignant lesions, the early stage dysplasia and carcinoma in situ, of ESCC tumor tissues. Differential polymerase chain reaction results showed slight increases in the EMS1 gene only in two of 10 ESCC tumor tissues, suggesting that EMS1 gene amplification is not the only mechanism for cortactin overexpression. In the mouse model induced by treatment with 4-nitroquinoline 1-oxide and arecoline, increased cortactin was detected in the epithelia with hyperkeratosis, papillomas, and ESCCs with invasion into the submucosa, respectively. Overall, we observed cortactin overexpression in early and late stages of human ESCCs and carcinogen-induced murine ESCCs, suggesting a role for cortactin in esophageal carcinogenesis.

KW - Arecoline

KW - Cortactin

KW - Esophageal squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=48649086992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48649086992&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2050.2007.00775.x

DO - 10.1111/j.1442-2050.2007.00775.x

M3 - Article

C2 - 19125793

AN - SCOPUS:48649086992

VL - 21

SP - 402

EP - 408

JO - Diseases of the Esophagus

JF - Diseases of the Esophagus

SN - 1120-8694

IS - 5

ER -